Previous Close | 0.8430 |
Open | 0.8590 |
Bid | 0.8184 x 200 |
Ask | 0.9411 x 100 |
Day's Range | 0.8326 - 0.9299 |
52 Week Range | 0.4400 - 12.8000 |
Volume | |
Avg. Volume | 1,224,476 |
Market Cap | 1.587M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -7.6400 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 35.00 |
VANCOUVER, British Columbia, May 28, 2024--Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide, announces that it has a hearing scheduled for June 25, 2024 before a Nasdaq Hearings Panel (the "Panel") regarding its plan to regain compliance with Nasdaq Listing Rule 5550(b) (the "Stockholders’ Equity Rule").
Key Takeaways; Cannabis Sector Agrify converted $13.8m debt to equity to regain Nasdaq compliance. Glass House Brands is seeking Canadian funding through shelf prospectus. TILT Holdings’ cannabis sales are stable despite vape supply disruptions, debt and stock dilution concern; analyst says. Key Takeaways; Psychedelic Sector Awakn recently concluded a feasibility study with Catalent Pharma. Lucy […]
VANCOUVER, British Columbia, February 16, 2024--Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide announces that the Company will effect a one-for-ten (1-10) reverse split of its common shares. The Company is effecting the reverse split in an effort to regain compliance with the $1.00 minimum bid price required for contin